<![CDATA[Optimal timing of surgery for locally advance rectal cancer: how we choose]]>
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 03
Abstract
<![CDATA[Locally advanced rectal cancer (LARC) is associated with a high risk of local recurrence and distant metastasis, making it difficult to be cured by surgery alone. Neoadjuvant chemoradiotherapy followed by surgery is the standard treatment for LARC, with reduced local recurrence rates. However, neoadjuvant chemoradiotherapy is associated with patients' urogenital and sexual dysfunction, which severely affecting their quality of life. Therefore, determining the optimal timing of surgery to balance oncologic and functional outcomes is crucial and challenging. We proposed that choosing the optimal timing of surgery based on preoperative risk assessment of LARC is an effective strategy. The patients with low to moderate risk of recurrence can be considered to perform surgery directly or have preoperative chemotherapy followed by radical surgery. Patients with high risk of recurrence should extend neoadjuvant therapy before surgery to improve oncologic outcomes. In this study we explored the optimal timing of radical surgery for LARC, providing a new idea for individualized and precise treatment of LARC.]]>
Authors and Affiliations
XIE Haiting, HU Yeting, LI Jun, DING Kefeng,
Research status and prospects of colorectal cancer vaccine
Colorectal cancer(CRC) ranks in third place in terms of incidence but second in terms of mortality. Cancer vaccine, as a novel immunotherapy, presents tumor antigens to human immune system and further elicits anti-tumor...
Continuous cardiac index in patients related with left ventricular ejection fraction in preanesthesia assessment for gastroenteroscopy
[Objective] To study both non-invasive continuous cardiac index (CCI) and risk factors of coronary heart disease related with left ventricular ejection fraction (LVEF). [Methods] Retrospective study was done at VIP Healt...
Clinical significance of combination of anti-angiogenesis, immune checkpoint inhibitors and chemotherapy in the neoadjuvant treatment of locally advanced gastric cancer
The combination of anti-angiogenesis, immune checkpoint inhibitors(ICIs) and chemotherapy(target-immune-chemo) has achieved initial results in the comprehensive treatment of gastric cancer. Experimental studies have show...
<![CDATA[Current status and development of laparoscopic hepatectomy]]>
<![CDATA[]]>
Study on oral microflora related to pancreatic cancer